NYSE Arca · NNVC
NanoViricides, Inc.
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarEarnings announcement for NNVC: Nov 13, 2026
NanoViricides, Inc. Common Stock is estimated to report earnings on 11/13/2026. The upcoming earnings date is derived from an algorithm based on a company's historical reporting dates. Our vendor, Zacks Investment Research, might revise this date in the future, once the company announces the actual earnings date. According to Zacks Investment Research, based on 1 analysts' forecasts, the consensus EPS forecast for the quarter is $-0.1. The reported EPS for the same quarter last year was $-0.1.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $-0.10 | $-0.10 | $-0.10 | 1 |
| Dec 2026 | $-0.11 | $-0.11 | $-0.11 | 1 |
| Mar 2027 | $-0.12 | $-0.12 | $-0.12 | 1 |
| Jun 2027 | $-0.13 | $-0.13 | $-0.13 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · MarketBeat · InvestorPlace · Fintel- RTTNews · May 28, 4:11 AM EDTTop Biotech Gainers: QTTB Has A Good Hair Day, GH Wins ACS Recommendation, Ebola Lifts SNGX, NNVX(RTTNews) – Today's Top Gainers list features Q32 Bio, which announced a $55 million private placement financing; Soligenix, which is exploring the suitability of its ThermoVax platform to fight the Bundibugyo strain of Ebola virus; P3 Health Partners, which recently reported str
- RTTNews · Jan 11, 10:55 PM ESTAfter-Hours Rally: Zentalis, LifeMD, And NanoViricides Among Top Gainers(RTTNews) – Several biotech and healthcare names posted notable gains in after-hours trading on Friday, with investors showing renewed interest in companies tied to drug development, healthcare services, and financing updates.
- MarketBeat · Dec 12, 9:51 AM EST2 Small-Cap Biotechs That Could Reward Patient InvestorsSpeculative investors and patience rarely go hand in hand. Nevertheless, if you’re looking to invest in the small-cap biotech sector, patience is a requirement. Most, if not all, of these companies are still in the clinical stage, meaning they have no commercially available drug
- InvestorPlace · May 2, 6:30 AM EDT3 Nanotech Stocks With the Potential to Make You an Overnight MillionaireInvestorPlace – Stock Market News, Stock Advice & Trading Tips
- Fintel · Feb 24, 7:19 AM ESTNanoViricides (NNVC) Price Target Increased by 23.81% to 6.63The average one-year price target for NanoViricides (NYSEAM:NNVC) has been revised to 6.63 / share. This is an increase of 23.81% from the prior estimate of 5.36 dated August 1, 2023. The price target is an average of many targets provided by analysts. The lat
- Fintel · Apr 18, 11:47 PM EDTEF Hutton Reiterates NanoViricides (NNVC) Buy RecommendationFintel reports that on April 18, 2023, EF Hutton reiterated coverage of NanoViricides (AMEX:NNVC) with a Buy recommendation.
- RTTNews · Aug 17, 7:47 AM EDTPre-market Movers: HIL, BBBY, JCSE, SAVA, MX…(RTTNews) – The following are some of the stocks making big moves in Wednesday's pre-market trading (as of 07.30 A.M. ET).
- RTTNews · May 26, 7:45 AM EDTPre-market Movers: NTNX, WKME, SNOW, ISPC, NNVC…(RTTNews) – The following are some of the stocks making big moves in Thursday's pre-market trading (as of 07.30 A.M. ET).
- Kwhen · Jan 18, 1:59 AM ESTNanoViricides Inc. Shares Approach 52-Week Low – Market MoverNanoViricides Inc. (NNVC) shares closed today at 1.7% above its 52 week low of $2.86, giving the company a market cap of $33M. The stock is currently down 21.8% year-to-date, down 11.3% over the past 12 months, and down 88.9%
- Kwhen · Jan 16, 9:23 PM ESTNanoViricides Inc. Shares Near 52-Week Low – Market MoverNanoViricides Inc. (NNVC) shares closed today at 1.7% above its 52 week low of $2.86, giving the company a market cap of $33M. The stock is currently down 21.8% year-to-date, down 11.3% over the past 12 months, and down 88.9%
- RTTNews · Nov 15, 7:25 AM ESTPre-market Movers: CREX, BTB, EYPT, OXBR, MICT…(RTTNews) – The following are some of the stocks making big moves in Monday's pre-market trading (as of 07.10 A.M. ET).
- InvestorPlace · Sep 27, 7:21 AM EDTToday’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on MondayInvestorPlace – Stock Market News, Stock Advice & Trading Tips
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for NanoViricides, Inc. from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.